Protein Expression Market By Expression Systems (Prokaryotic, Mammalian Cell), By Product (Reagents, Competent Cells), By Application (Therapeutic, Industrial), By End-use, And Segment Forecasts, 2014 - 2025

The global protein expression market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal antibodies,and vaccines is a major factor that propels growth of the market during forecast period. Thus, many biotechnology and pharmaceuticals companies have begun to concentrate on the development and manufacturing of advanced therapeutic proteins for the treatment of severe chronic diseases such as cancer, hemophilia, infectious diseases, anemia, and multiple sclerosis.
Increasing investment in the R&D, by biotechnology and pharmaceutical companies, is another major factor supporting the sector growth. The availability of new and advanced technologies to cater the needs of drugs & biologics product manufacturers boosts the adoption of protein expression products for research and manufacturing applications. In addition, several pharmaceutical and biotechnology manufacturers are undergoing collaborations and partnerships to achieve leadership in the sector. For instance, in December 2016, Takara Bio, Inc. signed a merger agreement with Rubicon Genomics, Inc. to strengthen its genomics business.
Further Key Findings From The Report Suggest:
‧ Prokaryotic expression systems segment was the largest revenue-generating amongst others owing to its large application in biologics and drug productions
‧ Mammalian cell expression systems is the fastest growing segment of the protein expression market owing to its growing demand for proteomics research and biologics manufacturing
‧ Reagents segment held the largest revenue share in the market, which is attributed to its repetitive purchase fortherapeutic, industrial, and research applications
‧ The services segment is projected to grow at highest rate due to increasing trend of outsourcing of protein expression services by research labs and drug manufacturers
‧ Therapeutic application segment was leading in 2016, due to high demand of therapeutic proteins for the treatment of cancer, infectious diseases, anemia, hemophilia, and multiple sclerosis
‧ The pharmaceutical and biotechnological companies segment dominated the sector in terms of revenue in 2016 due to rising focus on proteomics research and increasing production of biologics products
‧ North America was the leading regional market in 2016 and is expected to maintain its dominance during the forecast period, because of the presence of large number of biopharmaceutical and biotechnology companies in this region
‧ The Asia Pacific region is projected to grow at a highest CAGR during the forecast period owing to untapped opportunities in the developing countries including China and India
‧ Some of the major players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, and Takara Bio, Inc.

Table of Contents
Chapter 1 Research Methodology
1.1 Country Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Protein Expression Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Escalating demand for biologics
3.2.2 Increasing investment in R&D
3.2.3 Rising funding by government for proteomics and genomics research
3.3 Market Restraint Analysis
3.3.1 Stringent government rules and regulations
3.3.2 Intense competition among vendors
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by expression systems
3.4.2 Key opportunities prioritized, by product
3.4.3 Key opportunities prioritized, by application
3.4.4 Key opportunities prioritized, by end-use
3.5 Protein Expression - SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis - Porter’s
3.7 Protein Expression Market: Market Position Analysis, 2016
Chapter 4 Protein Expression Market: Expression Systems Estimates & Trend Analysis
4.1 Protein Expression Market: Expression Systems Movement Analysis
4.2 Prokaryotic Expression Systems
4.2.1 Prokaryotic expression systems market, 2014 - 2025 (USD Million)
4.3 Mammalian Cell Expression Systems
4.3.1 Mammalian cell expression systems market, 2014 - 2025 (USD Million)
4.4 Insect Cell Expression Systems
4.4.1 Insect cell expression systems market, 2014 - 2025 (USD Million)
4.5 Yeast Expression Systems
4.5.1 Yeast expression systems market, 2014 - 2025 (USD Million)
4.6 Other Expression Systems
4.6.1 Other expression systems market, 2014 - 2025 (USD Million)
Chapter 5 Protein Expression Market: Product Estimates & Trend Analysis
5.1 Protein Expression Market: Product Movement Analysis
5.2 Reagents
5.2.1 Reagents market, 2014 - 2025 (USD Million)
5.3 Competent Cells
5.3.1 Competent cells market, 2014 - 2025 (USD Million)
5.4 Expression Vectors
5.4.1 Expression vectors market, 2014 - 2025 (USD Million)
5.5 Services
5.5.1 Services market, 2014 - 2025 (USD Million)
5.6 Instruments
5.6.1 Instruments market, 2014 - 2025 (USD Million)
Chapter 6 Protein Expression Market: Application Estimates & Trend Analysis
6.1 Protein Expression Market: Application Movement Analysis
6.2 Therapeutic Applications
6.2.1 Therapeutic applications market, 2014 - 2025 (USD Million)
6.3 Industrial Applications
6.3.1 Industrial applications market, 2014 - 2025 (USD Million)
6.4 Research Applications
6.4.1 Research applications Market, 2014 - 2025 (USD Million)
Chapter 7 Protein Expression Market: End-use Estimates & Trend Analysis
7.1 Protein Expression Market: End-use Movement Analysis
7.2 Pharmaceutical and Biotechnological Companies
7.2.1 Pharmaceutical and biotechnological companies market, 2014 - 2025 (USD Million)
7.3 Academic Research
7.3.1 Academic research market, 2014 - 2025 (USD Million)
7.4 Contract Research Organizations
7.4.1 Contract research organizations market, 2014 - 2025 (USD Million)
Chapter 8 Protein Expression Market: Regional Estimates & Trend Analysis, by Expression Systems, Product, Application, End-use
8.1 Protein Expression Market Share By Region, 2016 & 2025
8.2 North America
8.2.1 North America protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.2.2 North America protein expression market, by product, 2014 - 2025 (USD Million)
8.2.3 North America protein expression market, by application, 2014 - 2025 (USD Million)
8.2.4 North America protein expression market, by end-use, 2014 - 2025 (USD Million)
8.2.5 U.S.
8.2.5.1 U.S. protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.2.5.2 U.S. protein expression market, by product, 2014 - 2025 (USD Million)
8.2.5.3 U.S. protein expression market, by application, 2014 - 2025 (USD Million)
8.2.5.4 U.S. protein expression market, by end-use, 2014 - 2025 (USD Million)
8.2.6 Canada
8.2.6.1 Canada protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.2.6.2 Canada protein expression market, by product, 2014 - 2025 (USD Million)
8.2.6.3 Canada protein expression market, by application, 2014 - 2025 (USD Million)
8.2.6.4 Canada protein expression market, by end-use, 2014 - 2025 (USD Million)
8.3 Europe
8.3.1 Europe protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.3.2 Europe protein expression market, by product, 2014 - 2025 (USD Million)
8.3.3 Europe protein expression market, by application, 2014 - 2025 (USD Million)
8.3.4 Europe protein expression market, by end-use, 2014 - 2025 (USD Million)
8.3.5 Germany
8.3.5.1 Germany protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.3.5.2 Germany protein expression market, by product, 2014 - 2025 (USD Million)
8.3.5.3 Germany protein expression market, by application, 2014 - 2025 (USD Million)
8.3.5.4 Germany protein expression market, by end-use, 2014 - 2025 (USD Million)
8.3.6 UK
8.3.6.1 UK protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.3.6.2 UK protein expression market, by product, 2014 - 2025 (USD Million)
8.3.6.3 UK protein expression market, by application, 2014 - 2025 (USD Million)
8.3.6.4 UK protein expression market, by end-use, 2014 - 2025 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.4.2 Asia Pacific protein expression market, by product, 2014 - 2025 (USD Million)
8.4.3 Asia Pacific protein expression market, by application, 2014 - 2025 (USD Million)
8.4.4 Asia Pacific protein expression market, by end-use, 2014 - 2025 (USD Million)
8.4.5 Japan
8.4.5.1 Japan protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.4.5.2 Japan protein expression market, by product, 2014 - 2025 (USD Million)
8.4.5.3 Japan protein expression market, by application, 2014 - 2025 (USD Million)
8.4.5.4 Japan protein expression market, by end-use, 2014 - 2025 (USD Million)
8.4.6 China
8.4.6.1 China protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.4.6.2 China protein expression market, by product, 2014 - 2025 (USD Million)
8.4.6.3 China protein expression market, by application, 2014 - 2025 (USD Million)
8.4.6.4 China protein expression market, by end-use, 2014 - 2025 (USD Million)
8.4.7 India
8.4.7.1 India protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.4.7.2 India protein expression market, by product, 2014 - 2025 (USD Million)
8.4.7.3 India protein expression market, by application, 2014 - 2025 (USD Million)
8.4.7.4 India protein expression market, by end-use, 2014 - 2025 (USD Million)
8.5 Latin America
8.5.1 Latin America protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.5.1.1 Latin America protein expression market, by product, 2014 - 2025 (USD Million)
8.5.1.2 Latin America protein expression market, by application, 2014 - 2025 (USD Million)
8.5.1.2 Latin America protein expression market, by end-use, 2014 - 2025 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.5.2.2 Brazil protein expression market, by product, 2014 - 2025 (USD Million)
8.5.2.3 Brazil protein expression market, by application, 2014 - 2025 (USD Million)
8.5.2.4 Brazil protein expression market, by end-use, 2014 - 2025 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.5.3.2 Mexico protein expression market, by product, 2014 - 2025 (USD Million)
8.5.3.3 Mexico protein expression market, by application, 2014 - 2025 (USD Million)
8.5.3.4 Mexico protein expression market, by end-use, 2014 - 2025 (USD Million)
8.6 MEA
8.6.1 MEA protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.6.2 MEA protein expression market, by product, 2014 - 2025 (USD Million)
8.6.3 MEA protein expression market, by application, 2014 - 2025 (USD Million)
8.6.4 MEA protein expression market, by end-use, 2014 - 2025 (USD Million)
8.6.5 South Africa
8.6.5.1 South Africa protein expression market, by expression systems, 2014 - 2025 (USD Million)
8.6.5.2 South Africa protein expression market, by product, 2014 - 2025 (USD Million)
8.6.5.3 South Africa protein expression market, by application, 2014 - 2025 (USD Million)
8.6.5.4 South Africa protein expression market, by end-use, 2014 - 2025 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Company Profiles
9.2.1 Agilent Technologies, Inc.
9.2.1.1 Company Overview
9.2.1.2 Financial Performance
9.2.1.3 Product Benchmarking
9.2.1.4 Strategic Initiatives
9.2.2 Thermo Fisher Scientific, Inc
9.2.2.1 Company Overview
9.2.2.2 Financial Performance
9.2.2.3 Product Benchmarking
9.2.2.4 Strategic Initiatives
9.2.3 Bio-Rad Laboratories, Inc.
9.2.3.1 Company Overview
9.2.3.2 Financial Performance
9.2.3.3 Product Benchmarking
9.2.3.4 Strategic Initiatives
9.2.4 Merck KGaA
9.2.4.1 Company Overview
9.2.4.2 Financial Performance
9.2.4.3 Product Benchmarking
9.2.4.4 Strategic Initiatives
9.2.5 Promega Corporation
9.2.5.1 Company Overview
9.2.5.2 Financial Performance
9.2.5.3 Product Benchmarking
9.2.5.4 Strategic Initiatives
9.2.6 New England Biolabs
9.2.6.1 Company Overview
9.2.6.2 Financial Performance
9.2.6.3 Product Benchmarking
9.2.6.4 Strategic Initiatives
9.2.7 Qiagen
9.2.7.1 Company Overview
9.2.7.2 Financial Performance
9.2.7.3 Product Benchmarking
9.2.7.4 Strategic Initiatives
9.2.8 Takara Bio, Inc.
9.2.8.1 Company Overview
9.2.8.2 Financial Performance
9.2.8.3 Product Benchmarking
9.2.8.4 Strategic Initiatives
9.2.9 Oxford Expression Technologies
9.2.9.1 Company Overview
9.2.9.2 Financial Performance
9.2.9.3 Product Benchmarking
9.2.9.4 Strategic Initiatives
9.2.10 Lucigen Corporation
9.2.10.1 Company Overview
9.2.10.2 Financial Performance
9.2.10.3 Product Benchmarking
9.2.10.4 Strategic Initiatives